triiodothyronine has been researched along with Left Ventricular Hypertrophy in 11 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with congestive heart failure (CHF) often have low serum triiodothyronine (T(3)) concentrations." | 3.75 | Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure. ( Danzi, S; Henderson, KK; Klein, I; Leya, G; Paul, JT; Samarel, AM, 2009) |
| "Low triiodothyronine is associated with left ventricular dysfunction and left ventricular hypertrophy in ESRD patients." | 3.73 | Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. ( Benedetto, F; Bonanno, G; Cutrupi, S; Malatino, LS; Mallamaci, F; Pizzini, P; Seminara, G; Tripepi, G; Zoccali, C, 2006) |
| "Hyperthyroidism was induced by daily intraperitoneal injection of thyroxine (T4) (600 microg/kg) with or without cilazapril (10 mg/kg per day, orally), and control rats were given by vehicle." | 1.31 | Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats. ( Asahi, T; Oshiro, Y; Shimabukuro, M; Takasu, N; Yoshida, H, 2001) |
| "Hyperthyroidism is associated with exercise intolerance." | 1.29 | Effects of hyperthyroidism on muscle blood flow during exercise in rats. ( Laughlin, MH; McAllister, RM; Sansone, JC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teixeira, RB | 1 |
| Zimmer, A | 1 |
| de Castro, AL | 1 |
| Carraro, CC | 1 |
| Casali, KR | 1 |
| Dias, IGM | 1 |
| Godoy, AEG | 1 |
| Litvin, IE | 1 |
| Belló-Klein, A | 1 |
| da Rosa Araujo, AS | 1 |
| Xu, G | 1 |
| Yan, Y | 1 |
| Liu, Y | 1 |
| Henderson, KK | 1 |
| Danzi, S | 1 |
| Paul, JT | 1 |
| Leya, G | 1 |
| Klein, I | 2 |
| Samarel, AM | 1 |
| Minakawa, M | 1 |
| Takeuchi, K | 1 |
| Ito, K | 1 |
| Tsushima, T | 1 |
| Fukui, K | 1 |
| Takaya, S | 1 |
| Fukuda, I | 1 |
| Zoccali, C | 1 |
| Benedetto, F | 1 |
| Mallamaci, F | 1 |
| Tripepi, G | 1 |
| Cutrupi, S | 1 |
| Pizzini, P | 1 |
| Malatino, LS | 1 |
| Bonanno, G | 1 |
| Seminara, G | 1 |
| Fernandes, ML | 1 |
| Ferro, EA | 1 |
| Beletti, ME | 1 |
| Resende, ES | 1 |
| McAllister, RM | 1 |
| Sansone, JC | 1 |
| Laughlin, MH | 1 |
| Biondi, B | 1 |
| Fazio, S | 1 |
| Carella, C | 1 |
| Amato, G | 1 |
| Cittadini, A | 1 |
| Lupoli, G | 1 |
| Saccà, L | 1 |
| Bellastella, A | 1 |
| Lombardi, G | 1 |
| Hamasaki, Y | 1 |
| Shinohara, O | 1 |
| Ishida, H | 1 |
| Hayashi, Y | 1 |
| Nakazawa, H | 1 |
| Ojamaa, K | 1 |
| Kenessey, A | 1 |
| Shenoy, R | 1 |
| Asahi, T | 1 |
| Shimabukuro, M | 1 |
| Oshiro, Y | 1 |
| Yoshida, H | 1 |
| Takasu, N | 1 |
11 other studies available for triiodothyronine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Exercise training versus T3 and T4 hormones treatment: The differential benefits of thyroid hormones on the parasympathetic drive of infarcted rats.
Topics: Animals; Echocardiography; Exercise Therapy; Fibrosis; Hypertrophy, Left Ventricular; Male; Myocardi | 2018 |
The cardiovascular disease risks of nonthyroidal illness syndrome and inflammatory responses on patients with chronic kidney disease: from the association to clinical prognosis.
Topics: Adult; Aged; Cardiovascular Diseases; Echocardiography; Female; Humans; Hypertrophy, Left Ventricula | 2014 |
Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Topics: Animals; Blood Pressure; Diastole; Disease Models, Animal; Gene Expression Regulation; Heart Failure | 2009 |
Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart.
Topics: Animals; Calcium-Transporting ATPases; Cells, Cultured; Disease Models, Animal; Disease Progression; | 2003 |
Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Case-Control Studies; Female; Humans; Hypertroph | 2006 |
Spironolactone effects on myocardium changes induced by thyroid hormone in rats.
Topics: Analysis of Variance; Animals; Body Weight; Heart; Heart Rate; Hypertrophy, Left Ventricular; Male; | 2007 |
Effects of hyperthyroidism on muscle blood flow during exercise in rats.
Topics: Animals; Citrate (si)-Synthase; Heart Rate; Hindlimb; Hyperthyroidism; Hypertrophy, Left Ventricular | 1995 |
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.
Topics: Adult; Arrhythmias, Cardiac; Blood Pressure; Cardiomegaly; Echocardiography; Electrocardiography; El | 1993 |
Decreased protein kinase C-epsilon expression in hypertrophied cardiac ventricles induced by triiodothyronine treatment in the rat.
Topics: Animals; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Calcium; Disease Models, Animal; Heart Ven | 2000 |
Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat.
Topics: Animals; Calcium-Transporting ATPases; Gene Expression; Hypertrophy, Left Ventricular; Kv1.5 Potassi | 2000 |
Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell S | 2001 |